UCB Presents Crohn’s Disease Therapy Evaluation Data For Cimzia at DDW

UCB Presents Crohn’s Disease Therapy Evaluation Data For Cimzia at DDW
Biopharmaceutical company UCB recently presented data on the study of the drug Cimzia for the treatment of Crohn’s disease at Digestive Disease Week 2015, which wraps up today in Washington, D.C. Cimzia was approved in the United States in 2008 for the reduction of symptoms associated with Crohn’s disease, as well as maintaining clinical responses in adults with a moderate

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *